Compass Therapeutics, Inc. (CMPX)
1.90
+0.05
(+2.70%)
USD |
NASDAQ |
Sep 18, 16:00
1.91
+0.01
(+0.53%)
Pre-Market: 09:22
Compass Therapeutics Total Long Term Debt (Quarterly) : 7.996M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.996M |
| March 31, 2026 | 8.418M |
| December 31, 2025 | 8.829M |
| September 30, 2025 | 9.234M |
| June 30, 2025 | 9.633M |
| March 31, 2025 | 6.272M |
| December 31, 2024 | 6.296M |
| September 30, 2024 | 6.32M |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.189M |
| December 31, 2023 | 0.536M |
| September 30, 2023 | 0.869M |
| June 30, 2023 | 1.197M |
| March 31, 2023 | 1.52M |
| December 31, 2022 | 1.838M |
| Date | Value |
|---|---|
| September 30, 2022 | 2.144M |
| June 30, 2022 | 2.444M |
| March 31, 2022 | 2.74M |
| December 31, 2021 | 3.048M |
| September 30, 2021 | 7.072M |
| June 30, 2021 | 9.215M |
| March 31, 2021 | 11.35M |
| December 31, 2020 | 9.334M |
| September 30, 2020 | 11.19M |
| June 30, 2020 | 13.04M |
| March 31, 2020 | 144.76M |
| December 31, 2019 | 144.74M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Capricor Therapeutics, Inc. | 89.56M |
| Ardelyx, Inc. | 254.64M |
| ARS Pharmaceuticals, Inc. | 96.68M |
| Upstream Bio, Inc. | 0.226M |
| Sionna Therapeutics, Inc. | 6.692M |